{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:53:10Z","timestamp":1786373590593,"version":"build-2736575974"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Pay-for-performance indicators and lack of knowledge about new drugs limit general practitioners' ability to identify target populations and perform urinary protein assays.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Choosing between several possible assays is associated with confusion and exposes general practitioners to the risk of inappropriate referrals to nephrologists.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Revising pay-for-performance indicators, drafting multidisciplinary guidelines, raising multiprofessional collaboration, and patient awareness should be considered.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Albuminuria testing is an easy way to identify, early on, a higher risk of cardiovascular and kidney morbidity and mortality in patients at risk. In France, the urine albumin-to-creatinine ratio is an indicator for Remuneration for Public Health Objectives (primary care pay-for-performance) for patients with diabetes or hypertension. These tests must be performed annually by General Practitioners (GPs), but are not sufficiently performed, although drug therapies depend on them. We wanted to understand the practice of urinary protein screening assays by means of a qualitative study on the experience of GPs in a French region, with a view to developing facilitating strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This qualitative, semiopragmatic, phenomenological study analyzed in-depth interviews held with a purposive sample (age, sex, training, type of practice, rural\/urban context) of 27 GPs, with triangulation of researchers until data saturation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>GPs recognized the assay as a systematic screening tool in accordance with the guidelines, but limited it to patients with diabetes or hypertension encouraged by primary care pay-for-performance. Noting that their intervention was limited to kidney-protective measures already in place and, unaware of the new drugs, they saw no benefits and considered it a nonpriority test. The existence of several urinary assays with varying intervention thresholds, changes in guidelines, and the fact that specialists in laboratory medicine can decide which test to use depending on reimbursement by the health insurance scheme, all contributed to GPs' confusion in prescribing and interpreting tests. One consequence of this was inappropriate referral to the nephrologist. These tests required them to adopt a patient-centered educational approach, making it difficult for certain patients to perform them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GPs were aware of guideline recommendations to screen for albuminuria in patients with diabetes and hypertension but had difficulty interpreting the results. Their lack of perceived clinical consequences and new drugs should be targeted to improve the situation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000000620","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T12:02:45Z","timestamp":1732190565000},"page":"367-376","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Obstacles and Opportunities for Albuminuria Testing On the Basis of the Perspective of Primary Care"],"prefix":"10.2215","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7122-2626","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Oude Engberink","sequence":"first","affiliation":[{"name":"Desbrest Institute of Epidemiology and Public Health (IDESP), INSERM, University of Montpellier, Montpellier, France"},{"name":"Department of General Practice, School of Medicine, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4228-4542","authenticated-orcid":false,"given":"Julie","family":"Marc","sequence":"additional","affiliation":[{"name":"Department of General Practice, School of Medicine, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Renk","sequence":"additional","affiliation":[{"name":"Department of General Practice, School of Medicine, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Serayet","sequence":"additional","affiliation":[{"name":"Department of General Practice, School of Medicine, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-5909","authenticated-orcid":false,"given":"G\u00e9rard","family":"Bourrel","sequence":"additional","affiliation":[{"name":"Desbrest Institute of Epidemiology and Public Health (IDESP), INSERM, University of Montpellier, Montpellier, France"},{"name":"Department of General Practice, School of Medicine, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-1415","authenticated-orcid":false,"given":"Olivier","family":"Moranne","sequence":"additional","affiliation":[{"name":"Desbrest Institute of Epidemiology and Public Health (IDESP), INSERM, University of Montpellier, Montpellier, France"},{"name":"Nephrology-Dialysis-Apheresis Department, University Hospital of N\u00eemes, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"issue":"11","key":"B2-20250326","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med."},{"issue":"7","key":"B3-20250326","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One."},{"issue":"3","key":"B4-20250326","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/ckj\/sfab240","article-title":"More on the invisibility of chronic kidney disease\u2026 and counting","volume":"15","author":"Carriazo","year":"2022","journal-title":"Clin Kidney J."},{"issue":"6","key":"B5-20250326","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.diabet.2012.08.004","article-title":"Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007)","volume":"38","author":"Assogba","year":"2012","journal-title":"Diabetes Metab."},{"issue":"9","key":"B6-20250326","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1681\/ASN.2020030277","article-title":"Early detection of CKD: implications for low-income, middle-income, and high-income countries","volume":"31","author":"Tonelli","year":"2020","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"B7-20250326","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/dme.12783","article-title":"Impact of socio-economic position on health and quality of care in adults with type 2 diabetes in France: the Entred 2007 study","volume":"32","author":"Fosse-Edorh","year":"2015","journal-title":"Diabet Med."},{"issue":"10","key":"B8-20250326","first-page":"170","article-title":"L\u2019hypertension art\u00e9rielle en France: pr\u00e9valence, traitement et contr\u00f4le en 2015 et \u00e9volutions depuis 2006","author":"Perrine","year":"2018","journal-title":"Bull Epid\u00e9miol Hebd."},{"issue":"5","key":"B9-20250326","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.kint.2023.08.008","article-title":"Measuring albuminuria or proteinuria: does one answer fit all?","volume":"104","author":"Harrison","year":"2023","journal-title":"Kidney Int."},{"issue":"1","key":"B10-20250326","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3949\/ccjm.81a.13040","article-title":"Albuminuria: when urine predicts kidney and cardiovascular disease","volume":"81","author":"Stephen","year":"2014","journal-title":"Cleve Clin J Med."},{"issue":"6","key":"B11-20250326","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.clinthera.2010.06.013","article-title":"Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from The Netherlands","volume":"32","author":"Boersma","year":"2010","journal-title":"Clin Ther."},{"issue":"11","key":"B12-20250326","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: a review from the European renal and cardiovascular medicine working group of the European renal association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc Res."},{"issue":"13","key":"B13-20250326","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA."},{"issue":"1","key":"B14-20250326","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12875-022-01910-9","article-title":"Albuminuria testing and nephrology care among insured US adults with chronic kidney disease: a missed opportunity","volume":"23","author":"Chu","year":"2022","journal-title":"BMC Prim Care."},{"issue":"1","key":"B15-20250326","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12882-021-02394-y","article-title":"Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations \u2013 a registry-based analysis","volume":"22","author":"Bramlage","year":"2021","journal-title":"BMC Nephrol."},{"issue":"4S","key":"B16-20250326","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"issue":"9","key":"B17-20250326","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.ekir.2022.05.033","article-title":"Low adherence to kidney disease: improving global outcomes 2012 CKD clinical practice guidelines despite clear evidence of utility","volume":"7","author":"James","year":"2022","journal-title":"Kidney Int Rep."},{"issue":"7","key":"B18-20250326","doi-asserted-by":"crossref","first-page":"e2326230","DOI":"10.1001\/jamanetworkopen.2023.26230","article-title":"Estimated prevalence and testing for albuminuria in US adults at risk for chronic kidney disease","volume":"6","author":"Chu","year":"2023","journal-title":"JAMA Netw Open."},{"issue":"9","key":"B22-20250326","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/ijcp.12454","article-title":"Prevalence and management of chronic kidney disease in primary care patients in the UK","volume":"68","author":"Jameson","year":"2014","journal-title":"Int J Clin Pract."},{"key":"B23-20250326","doi-asserted-by":"crossref","first-page":"2054358117703059","DOI":"10.1177\/2054358117703059","article-title":"Quality of care for patients with chronic kidney disease in the primary care setting: a retrospective cohort study from ontario, Canada","volume":"4","author":"Nash","year":"2017","journal-title":"Can J kidney Health Dis."},{"issue":"9","key":"B24-20250326","doi-asserted-by":"crossref","first-page":"e1910704","DOI":"10.1001\/jamanetworkopen.2019.10704","article-title":"Quality of chronic kidney disease management in Canadian primary care","volume":"2","author":"Bello","year":"2019","journal-title":"JAMA Netw Open."},{"key":"B25-20250326","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2369-15-64","article-title":"Primary care physicians\u2019 familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study","volume":"15","author":"Abdel-Kader","year":"2014","journal-title":"BMC Nephrol."},{"issue":"5","key":"B26-20250326","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3122\/jabfm.2015.05.150070","article-title":"Chronic kidney disease guideline implementation in primary care: a qualitative report from the TRANSLATE CKD study","volume":"28","author":"Vest","year":"2015","journal-title":"J Am Board Fam Med."},{"issue":"2","key":"B27-20250326","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40620-023-01838-y","article-title":"General practitioners\u2019 representation of early-stage CKD is a barrier to adequate management and patient empowerment: a phenomenological study","volume":"37","author":"Oude Engberink","year":"2024","journal-title":"J Nephrol."},{"issue":"575","key":"B28-20250326","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3399\/bjgp10X502100","article-title":"How ready is general practice to improve quality in chronic kidney disease? A diagnostic analysis","volume":"60","author":"Crinson","year":"2010","journal-title":"Br J Gen Pract."},{"issue":"1","key":"B29-20250326","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12875-018-0736-3","article-title":"General practitioners\u2019 perspectives on management of early-stage chronic kidney disease: a focus group study","volume":"19","author":"Van Dipten","year":"2018","journal-title":"BMC Fam Pract."},{"issue":"3","key":"B30-20250326","doi-asserted-by":"crossref","first-page":"e010337","DOI":"10.1136\/bmjopen-2015-010337","article-title":"Understanding tensions and identifying clinician agreement on improvements to early-stage chronic kidney disease monitoring in primary care: a qualitative study","volume":"6","author":"Simmonds","year":"2016","journal-title":"BMJ Open."},{"issue":"6","key":"B31-20250326","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care."},{"issue":"4","key":"B33-20250326","doi-asserted-by":"crossref","first-page":"737","DOI":"10.34067\/KID.0006302020","article-title":"Qualitative research in nephrology: an introduction to methods and critical appraisal","volume":"2","author":"Amir","year":"2021","journal-title":"Kidney360."},{"issue":"3","key":"B34-20250326","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/hex.13430","article-title":"The chronic disease Self-Management Programme: a phenomenological study for empowering vulnerable patients with chronic diseases included in the EFFICHRONIC project","volume":"25","author":"Fracso","year":"2022","journal-title":"Health Expect."},{"issue":"10","key":"B35-20250326","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/08870440903194015","article-title":"What is an adequate sample size? Operationalising data saturation for theory-based interview studies","volume":"25","author":"Francis","year":"2010","journal-title":"Psychol Health."},{"issue":"5","key":"B36-20250326","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.08720816","article-title":"A population-based analysis of quality indicators in CKD","volume":"12","author":"Manns","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B37-20250326","doi-asserted-by":"crossref","first-page":"e008480","DOI":"10.1136\/bmjopen-2015-008480","article-title":"What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial","volume":"6","author":"Nihat","year":"2016","journal-title":"BMJ Open."},{"issue":"6","key":"B38-20250326","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1161\/HYPERTENSIONAHA.120.15956","article-title":"Association of albuminuria levels with the prescription of renin-angiotensin system blockade","volume":"76","author":"Qiao","year":"2020","journal-title":"Hypertension."},{"issue":"6","key":"B39-20250326","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/eurheartj\/ehab853","article-title":"The \u201cTen Commandments\u201d of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"43","author":"Adamo","year":"2022","journal-title":"Eur Heart J."},{"issue":"6","key":"B40-20250326","first-page":"804","article-title":"Dyslipidemia and prevention of atherosclerotic cardiovascular disease in the elderly","volume":"112","author":"Lucchi","year":"2021","journal-title":"Minerva Med."},{"issue":"6","key":"B41-20250326","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1053\/j.ajkd.2013.06.016","article-title":"Day-to-day variability in spot urine albumin-creatinine ratio","volume":"62","author":"Naresh","year":"2013","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"B42-20250326","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M23-2814","article-title":"Association of albuminuria with chronic kidney disease progression in persons with chronic kidney disease and normoalbuminuria: a cohort study","volume":"177","author":"Verma","year":"2024","journal-title":"Ann Intern Med."},{"issue":"1","key":"B43-20250326","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Chronic Kidney Disease Prognosis Consortium: lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int."},{"issue":"17","key":"B44-20250326","first-page":"zwae189","article-title":"The relationship between low levels of albuminuria and mortality among adults without major cardiovascular risk factors","volume":"13","author":"Claudel","year":"2024","journal-title":"Eur J Prev Cardiol."},{"issue":"3","key":"B45-20250326","first-page":"61","article-title":"Barriers to the successful practice of chronic kidney diseases at the primary health care level; a systematic review","volume":"3","author":"Junaid Nazar","year":"2014","journal-title":"J Ren Inj Prev."},{"issue":"4","key":"B46-20250326","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000448294","article-title":"Medical neighborhood model for the care of chronic kidney disease patients","volume":"44","author":"Smith","year":"2016","journal-title":"Am J Nephrol."},{"issue":"5","key":"B47-20250326","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1053\/j.ajkd.2019.05.003","article-title":"Follow-up of abnormal estimated GFR results within a large integrated health care delivery system: a mixed-methods study","volume":"74","author":"Danforth","year":"2019","journal-title":"Am J Kidney Dis."},{"issue":"16","key":"B48-20250326","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.3390\/jcm11164779","article-title":"Comparison of the 2013 and 2019 nationwide surveys on the management of chronic kidney disease by general practitioners in Japan","volume":"11","author":"Tatematsu","year":"2022","journal-title":"J Clin Med."},{"issue":"8","key":"B49-20250326","doi-asserted-by":"crossref","first-page":"e0221325","DOI":"10.1371\/journal.pone.0221325","article-title":"Primary care physicians\u2019 perceptions of barriers and facilitators to management of chronic kidney disease: a mixed methods study","volume":"14","author":"Sperati","year":"2019","journal-title":"PLoS One."},{"issue":"10","key":"B50-20250326","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/nep.12856","article-title":"Barriers and facilitators to opportunistic chronic kidney disease screening by general practice nurses","volume":"22","author":"Sinclair","year":"2017","journal-title":"Nephrology (Carlton)."},{"issue":"7","key":"B51-20250326","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1681\/ASN.2018101042","article-title":"The primary-secondary care partnership to improve outcomes in chronic kidney disease (PSP-CKD) study: a cluster randomized trial in primary care","volume":"30","author":"Major","year":"2019","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"B52-20250326","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2215\/CJN.0000000000000305","article-title":"Nurse practitioner care compared with primary care or nephrologist care in early CKD","volume":"18","author":"James","year":"2023","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B53-20250326","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12882-016-0383-7","article-title":"Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study","volume":"17","author":"Chang","year":"2016","journal-title":"BMC Nephrol."},{"issue":"1","key":"B54-20250326","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/0004563217690416","article-title":"The Cornish experience of the ASSIST-CKD project","volume":"55","author":"Barton","year":"2018","journal-title":"Ann Clin Biochem."},{"key":"B55-20250326","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12882-015-0154-x","article-title":"Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis","volume":"16","author":"Samal","year":"2015","journal-title":"BMC Nephrol."},{"issue":"4","key":"B56-20250326","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/fampra\/cmw131","article-title":"Web-based consultation between general practitioners and nephrologists: a cluster randomized controlled trial","volume":"34","author":"van Gelder","year":"2017","journal-title":"Fam Pract."},{"issue":"1","key":"B57-20250326","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12882-021-02533-5","article-title":"Online clinical pathway for chronic kidney disease management in primary care: a retrospective cohort study","volume":"22","author":"Donald","year":"2021","journal-title":"BMC Nephrol."},{"issue":"1","key":"B58-20250326","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12882-018-1156-2","article-title":"Validating laboratory defined chronic kidney disease in the electronic health record for patients in primary care","volume":"20","author":"Frigaard","year":"2019","journal-title":"BMC Nephrol."},{"issue":"2","key":"B59-20250326","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1053\/j.ajkd.2018.01.058","article-title":"Impact of a primary care CKD registry in a us public safety-net health care delivery system: a pragmatic randomized trial","volume":"72","author":"Tuot","year":"2018","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B60-20250326","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1186\/s12913-022-08691-y","article-title":"Monitoring and management of chronic kidney disease in ambulatory care - analysis of clinical and claims data from a population-based study","volume":"22","author":"Weckmann","year":"2022","journal-title":"BMC Health Serv Res."},{"issue":"4","key":"B61-20250326","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3122\/jabfm.2018.04.170459","article-title":"What patients with mild-to-moderate kidney disease know, think, and feel about their disease: an in-depth interview study","volume":"31","author":"van Dipten","year":"2018","journal-title":"J Am Board Fam Med."},{"issue":"10","key":"B62-20250326","doi-asserted-by":"crossref","first-page":"e041788","DOI":"10.1136\/bmjopen-2020-041788","article-title":"Perceived barriers and facilitators to chronic kidney disease care among patients in Singapore: a qualitative study","volume":"10","author":"Hwang","year":"2020","journal-title":"BMJ Open."},{"issue":"10407","key":"B63-20250326","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0140-6736(23)00876-0","article-title":"Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in The Netherlands (THOMAS): a prospective, randomised, open-label implementation study","volume":"402","author":"van Mil","year":"2023","journal-title":"Lancet."},{"issue":"1","key":"B64-20250326","first-page":"121","article-title":"eMAP:CKD: electronic diagnosis and management assistance to primary care in chronic kidney disease","volume":"33","author":"Pefanis","year":"2018","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"B65-20250326","first-page":"e107","article-title":"Physician and patient tools to improve chronic kidney disease care","volume":"24","author":"Sequist","year":"2018","journal-title":"Am J Manag Care."},{"issue":"8","key":"B66-20250326","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s40620-022-01353-6","article-title":"\u201cThe Disease Awareness Innovation Network\u201d for chronic kidney disease identification in general practice","volume":"35","author":"Pesce","year":"2022","journal-title":"J Nephrol."},{"key":"B67-20250326","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13012-016-0413-7","article-title":"Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review","volume":"11","author":"Tsang","year":"2016","journal-title":"Implement Sci."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:47:08Z","timestamp":1786369628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000620"}},"subtitle":["A Qualitative Study"],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000620","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"2024-07-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}